SEC Form 4 · accession 0001209191-16-112623
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Jl Rieflin
Director
Period of report
Mar 31, 2016
Accepted (ET)
Apr 4, 2016 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 31, 2016 | M | 30,000 | $6.92 | A | 30,000 | I | By Trust |
| Common StockF2 | Mar 31, 2016 | M | 7,500 | $6.74 | A | 37,500 | I | By Trust |
| Common StockF2 | Mar 31, 2016 | M | 12,500 | $5.20 | A | 50,000 | I | By Trust |
| Common StockF2 | Mar 31, 2016 | M | 15,000 | $5.11 | A | 65,000 | I | By Trust |
| Common StockF2 | Mar 31, 2016 | M | 24,000 | $14.22 | A | 89,000 | I | By Trust |
| Common Stock | holding | — | — | — | 853 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $6.92 | Mar 31, 2016 | M | 30,000 | D | — | Mar 31, 2021 | Common Stock | 30,000 | 0 | D |
| Stock Option (right to buy)F3 | $6.74 | Mar 31, 2016 | M | 7,500 | D | — | May 25, 2021 | Common Stock | 7,500 | 0 | D |
| Stock Option (right to buy)F3 | $5.20 | Mar 31, 2016 | M | 12,500 | D | — | May 30, 2022 | Common Stock | 12,500 | 0 | D |
| Stock Option (right to buy)F3 | $5.11 | Mar 31, 2016 | M | 15,000 | D | — | Jun 6, 2023 | Common Stock | 15,000 | 0 | D |
| Stock Option (right to buy)F3 | $14.22 | Mar 31, 2016 | M | 24,000 | D | — | May 29, 2024 | Common Stock | 24,000 | 0 | D |
Explanation of responses
- F1Represents a "cash exercise" of stock options pursuant to which the reporting person paid to the Issuer the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.
- F2Shares held by a family trust.
- F3This option is fully vested and exercisable.